Drawing for YOUR FAVORITE GENES IN YOUR FAVORITE CELL

USPTO serial 87069198

YOUR FAVORITE GENES IN YOUR FAVORITE CELL

Reviewed by CopyMark Law Group

Reg. 6166553Status 700Renewal
Filing date
Status date
Registration date
Oct 6, 2020
Examiner
AGOSTO, GISELLE MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with YOUR FAVORITE GENES IN YOUR FAVORITE CELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Courtney Thompson

Courtney Thompson Fredrikson & Byron, P.A.200 S. Sixth StreetSuite 4000Minneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
042Custom cell-line engineering services; Scientific research in the field of genetics and genetic engineering, namely, gene-editing services, DNA modeling services, gene engineering services, establishing patient genotypes; Bio-technology, pharmaceutical and scientific testing for scientific research purposes, research and development services relating to genetics; biological research; pharmaceutical research services; drug discovery services; Scientific research and development services for lead identification and validation; Scientific research and development services for target identification and validation; Pharmaceutical research, namely, identification of patient-relevant drug targets, optimization of drug candidates for clinical development; Laboratory diagnostic services for research purposes, namely, diagnosis of genetic mutations for clinical or research purposes and the design of molecular reference standards for assay development, clinical diagnostic quality control and proficiency schemes for the medical diagnostic services industry; medicinal research services, namely, hit discovery and hit to lead services; research and development services in the nature of creating libraries and collections of cells and cell lines, chemicals and compounds; research and development services in the nature of creating libraries and collections of normal and mutated genes; Scientific research and development services relating to targeting therapies to individuals; Scientific research and development services relating to combining therapies for individuals; research and development relating to reagents; Scientific research in the field of disease modeling; Medical and scientific research, namely, designing and conducting clinical trials for others; research and development in re-positioning existing drugs from other therapeutic indicationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 29, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 8, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 8, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 8, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 8, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 8, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 8, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 6, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 1, 2020DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Aug 28, 2020MREINOTICE OF REINSTATEMENT E-MAILED—
Aug 27, 2020PC.DPETITION TO DIRECTOR DISMISSED—
Aug 27, 2020RGIAREINSTATEMENT GRANTED - INADVERTENTLY ABANDONED—
Aug 27, 2020APETASSIGNED TO PETITION STAFF—
Aug 24, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 24, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 2, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 2, 2020TPDRTEAS PETITION TO DIRECTOR RECEIVED—
Mar 31, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 31, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 31, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 31, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 24, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 23, 2020EX5GSOU EXTENSION 5 GRANTED—
Jan 23, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 20, 2020EXT5SOU EXTENSION 5 FILED—
Jan 20, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 20, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 20, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 18, 2019EX4GSOU EXTENSION 4 GRANTED—
Jul 18, 2019EXT4SOU EXTENSION 4 FILED—
Jul 18, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 22, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 18, 2019EX3GSOU EXTENSION 3 GRANTED—
Jan 18, 2019EXT3SOU EXTENSION 3 FILED—
Jan 18, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 12, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 11, 2018EX2GSOU EXTENSION 2 GRANTED—
Sep 7, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 19, 2018NREVNOTICE OF REVIVAL - E-MAILED—
Jul 19, 2018TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jul 19, 2018PETGPETITION TO REVIVE-GRANTED—
Jul 19, 2018PROATEAS PETITION TO REVIVE RECEIVED—
Jul 18, 2018EXT2SOU EXTENSION 2 FILED—
Jan 20, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 18, 2018EX1GSOU EXTENSION 1 GRANTED—
Jan 18, 2018EXT1SOU EXTENSION 1 FILED—
Jan 18, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 18, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 23, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 23, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 18, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Apr 18, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 18, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 18, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 28, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 27, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 27, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2016DOCKASSIGNED TO EXAMINER—
Jun 20, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 16, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance